CVS HEALTH CORP Executive Salaries & Other Compensation | Salary.com (2024)

  • Company
  • Executives
  • Board Members
  • Compare Executives
  • Job Openings

Employers: Find Surveys For This Job Employers: Price Your Company Jobs Employees: Get a Salary Increase

CVS HEALTH CORP Executive Salaries & Other Compensation | Salary.com (6) Coronavirus Tips – Working and Protection

CVS HEALTH CORP

Compensation by Company
Employers Seeking efficiency in executive compensation benchmarking? Unlock Efficiency in Executive Compensation Benchmarking with CompAnalyst Executive CompAnalyst Executive

CVS HEALTH CORP Executive Salaries & Other Compensation | Salary.com (7)

Data Year:

2023

2022

Select Other Years

2021 2020 2019

For its 2023 fiscal year, CVS HEALTH CORP, listed the following executives on its annual proxy statement to the SEC

Equity

Cash Compensation

Other

Fiscal Year Ended in 2023

Name And Title Total Compensation Pay Rank By Title In Healthcare industry
Karen S. Lynch
President and Chief Executive Officer
Total Compensation $21,615,034 View details Pay Rank By Title In Healthcare industry #1 View more
Shawn M. Guertin
Former Executive Vice President, Chief Financial Officer and President of Health Services
Total Compensation $12,494,134 View details Pay Rank By Title In Healthcare industry #1 View more
Prem S. Shah
Executive Vice President, Chief Pharmacy Officer and President of Pharmacy & Consumer Wellness
Total Compensation $8,582,366 View details Pay Rank By Title In Healthcare industry #2 View more
Tilak Mandadi
Executive Vice President and Chief Digital, Data, Analytics and Technology Officer
Total Compensation $8,881,845 View details Pay Rank By Title In Healthcare industry #1 View more
Samrat S. Khichi
Executive Vice President, Chief Policy Officer and General Counsel
Total Compensation $11,886,503 View details Pay Rank By Title In Healthcare industry #1 View more
Thomas F. Cowhey
Senior Vice President and Interim Chief Financial Officer
Total Compensation $4,577,842 View details Pay Rank By Title In Healthcare industry #1 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at CVS HEALTH CORP as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. CVS HEALTH CORP income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. CVS HEALTH CORP annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Karen S. Lynch
President and Chief Executive Officer
Total Cash $4,492,000 Equity $16,499,963 Other $623,071 Total Compensation $21,615,034
Shawn M. Guertin
Former Executive Vice President, Chief Financial Officer and President of Health Services
Total Cash $2,428,583 Equity $9,999,979 Other $65,572 Total Compensation $12,494,134
Prem S. Shah
Executive Vice President, Chief Pharmacy Officer and President of Pharmacy & Consumer Wellness
Total Cash $2,371,000 Equity $5,999,926 Other $211,440 Total Compensation $8,582,366
Tilak Mandadi
Executive Vice President and Chief Digital, Data, Analytics and Technology Officer
Total Cash $2,246,000 Equity $6,499,983 Other $135,862 Total Compensation $8,881,845
Samrat S. Khichi
Executive Vice President, Chief Policy Officer and General Counsel
Total Cash $3,379,409 Equity $8,499,944 Other $7,150 Total Compensation $11,886,503
Thomas F. Cowhey
Senior Vice President and Interim Chief Financial Officer
Total Cash $1,559,250 Equity $2,749,887 Other $268,705 Total Compensation $4,577,842

CEO Pay Ratio

For its 2023 fiscal year, CVS HEALTH CORP, listed the following CEO pay ratio data on its annual proxy statement to the SEC.

CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Karen S. Lynch CEO Pay $21,630,264 Median Employee Pay $55,237 CEO Pay Ratio 392:1

Board of Directors in CVS HEALTH CORP

For its 2023 fiscal year, CVS HEALTH CORP, listed the following board members on its annual proxy statement to the SEC.

Name Total COMPENSATION
Alecia A. DeCoudreaux Total Cash $301,500
Anne M. Finucane Total Cash $321,500
C. David Brown, II Total Cash $321,500
Edward J. Ludwig Total Cash $314,000
Fernando Aguirre Total Cash $318,167
J. Scott Kirby Total Cash $195,417
Jean-Pierre Millon Total Cash $321,500
Jeffrey R. Balser, M.D, Ph.D. Total Cash $301,500
Mary L. Schapiro Total Cash $301,500
Michael F. Mahoney Total Cash $167,500
Nancy-Ann M. DeParle Total Cash $321,500
Roger N. Farah Total Cash $576,500

Browse Board of Directors By First Name

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Browse Executives by First Name

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Browse Companies by Company Name

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • #

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.

CVS HEALTH CORP Executive Salaries & Other Compensation | Salary.com (2024)
Top Articles
Latest Posts
Article information

Author: Jamar Nader

Last Updated:

Views: 6255

Rating: 4.4 / 5 (75 voted)

Reviews: 82% of readers found this page helpful

Author information

Name: Jamar Nader

Birthday: 1995-02-28

Address: Apt. 536 6162 Reichel Greens, Port Zackaryside, CT 22682-9804

Phone: +9958384818317

Job: IT Representative

Hobby: Scrapbooking, Hiking, Hunting, Kite flying, Blacksmithing, Video gaming, Foraging

Introduction: My name is Jamar Nader, I am a fine, shiny, colorful, bright, nice, perfect, curious person who loves writing and wants to share my knowledge and understanding with you.